Preclinical Development of SHR-1819, a Potent Humanized IL-4Rα Antibody for Treating Type 2 Inflammatory Diseases

• Main Authors: Zhao G (Author), Wang Z (Author), Zhang J (Author), Lin Y (Author), Zhou T (Author), Liu K (Author), Yang C (Author), Liao C (Author)
• Format: Book
• Published: Dove Medical Press, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Guolin Zhao,1,2 Zhijun Wang,1,2 Jun Zhang,1,2 Yuan Lin,1,2 Tang Zhou,1,2 Kaili Liu,1,2 Changyong Yang,1 Cheng Liao1 1Department of Preclinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lianyungang, Jiangsu, People's Republic of China; 2Department of Preclinical Resear...